+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Systematic Litertaure Review Of Direct Health Care Costs For Cardiovascular Events Among European Patients With Dyslipidemia Or High Cardiovascular Risk



Systematic Litertaure Review Of Direct Health Care Costs For Cardiovascular Events Among European Patients With Dyslipidemia Or High Cardiovascular Risk



Value in Health 18(7): A387




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058960986

Download citation: RISBibTeXText

PMID: 26532185

DOI: 10.1016/j.jval.2015.09.849


Related references

Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception. Clinica e Investigacion en Arteriosclerosis 26(6): 274-284, 2015

High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk. Journal of the American Heart Association 7(15): E008740, 2018

Assessment of the effect of ramipril therapy on direct health care costs for first and recurrent strokes in high-risk cardiovascular patients using data from the Heart Outcomes Prevention Evaluation (HOPE) Study. Clinical Therapeutics 25(4): 1248-1261, 2003

Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis. Journal of Cardiovascular Pharmacology 57(2): 267-272, 2011

Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients. Diabetes and Vascular Disease Research 14(5): 400-406, 2017

PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis. Internal and Emergency Medicine 12(7): 1043-1053, 2017

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia. Clinicoeconomics and Outcomes Research 7: 337-345, 2015

Fish oil administration in older adults with cardiovascular disease or cardiovascular risk factors: is there potential for adverse events? A systematic review of the literature. International Journal of Cardiology 168(4): 4371-4375, 2013

Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 51(14): 923-929, 2006

Incidence of myocardial infarction and stroke fatal events and risk of cardiovascular events in rheumatoid arthritis patients. Systematic review of the literature. Annals of the Rheumatic Diseases 66(Suppl. 2): 358-359, 2007

Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis 6(3): 444-450, 2008

Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review. Journal of Clinical and Translational Hepatology 6(2): 119-126, 2018

Cardiovascular risk assessments in chronic myeloid leukemia allow identification of patients at high risk of cardiovascular events during treatment with nilotinib. American Journal of Hematology 90(5): E100-E101, 2015

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105(14): 1650-1655, 2002

All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study. Vascular Health and Risk Management 14: 383-392, 2018